
亚太地区镍钛诺医疗器械市场预测至 2028 年 - COVID-19 影响和区域分析(按产品(镍钛诺支架、镍钛诺导丝、镍钛诺过滤器、镍钛诺篮、镍钛诺导管等)和应用(骨科、血管、牙科和胃肠病学)
No. of Pages: 141 | Report Code: TIPRE00023712 | Category: Life Sciences
No. of Pages: 141 | Report Code: TIPRE00023712 | Category: Life Sciences
镍钛诺是指镍和钛的合金,它正迅速成为各种成分的首选金属医疗保健行业的医疗设备。镍钛诺广泛应用于自膨胀移植物、篮子、过滤器、移植物支撑系统等。镍钛诺合金以其超弹性和热形状记忆而闻名。
亚太地区镍钛诺医疗器械市场预计将从2021年的35.8136亿美元增至2028年的60.4205亿美元;预计 2021 年至 2028 年复合年增长率为 7.8%。市场的增长归因于微创手术 (MIS) 的采用不断增加,以及全球镍钛诺设备不断进步的技术进步正在推动市场发展。然而,包括连接和组装、电镀和涂层、机械加工、冲压和成型在内的制造挑战可能会阻碍市场的增长。
微创技术的使用外科手术已经发展了医学科学中外科手术的范式。 MIS 的优点,如切口更小、疼痛减轻、并发症更少、失血量最少和住院时间更短,极大地影响了 MIS 的采用。 MIS 的日益普及主要得益于 MIS 的优势,它同样有助于利用专门用于机器人手术和腹腔镜手术的镍钛合金医疗设备的增长。根据一篇研究文章“腹腔镜手术后患者的管理” 2018 年发布的报告显示,全世界每年进行约 1500 万例腹腔镜手术。通过 MIS 进行的程序数量的增加可能会在预测期内推动市场。此外,世界各地对镍钛合金支架的需求不断增长,以治疗日益流行的 CVD 和 PVD。因此,各地区正在开展各种研究来开发 3D 打印镍钛合金支架。镍钛诺医疗器械领域的此类创新利用了更多的产品开发,预计将成为市场运营公司的趋势引领者。尽管如此,不断增长的技术进步可能会影响预测期内市场的增长。
亚太地区国家预计将面临由于不断增长的 COVID-19 带来的巨大挑战。考虑到经济运行和地理条件,疫情的爆发对亚太低收入国家的医疗设备、配件制造商以及医疗基础设施短缺带来的其他问题造成了影响。因此,接种疫苗后的患者正在接受未决的医疗程序,例如手术、牙科治疗等。自大流行开始以来,该地区的医疗保健系统已恢复其能力。然而,先进治疗方法的发展和死亡率的降低赢得了医生和患者的信心。因此,预计对该地区镍钛诺医疗器械市场的负面影响较小。
亚太镍钛诺医疗器械市场按产品细分为镍钛诺支架、镍钛诺导丝、镍钛诺过滤器、镍钛诺篮、镍钛诺导管等。 2020 年,按产品划分,镍钛诺支架细分市场占据最大市场份额。预计同一细分市场在预测期内将以显着的复合年增长率增长。
亚太地区镍钛诺医疗器械市场按应用细分为骨科、血管、牙科和胃肠病学。 2020 年,按应用划分,血管细分市场占据最大市场份额。此外,类似的细分市场预计在未来几年将以最快的速度增长。
与本亚太镍钛诺医疗器械市场报告相关的一些主要和二手来源是印度医疗器械行业协会(AMED)、中国国家药品监督管理局(NIMPA)、国家卫生和家庭福利研究所(NIHFW)和印度质量委员会(QCI)。
< p>< p>
按产品
按应用< /span>
Strategic insights for Asia Pacific Nitinol Medical Devices involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 3,581.36 Million |
Market Size by 2028 | US$ 6,042.05 Million |
Global CAGR (2021 - 2028) | 7.8% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 产品
|
Regions and Countries Covered | 亚太地区
|
Market leaders and key company profiles |
The regional scope of Asia Pacific Nitinol Medical Devices refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Nitinol Medical Devices Market is valued at US$ 3,581.36 Million in 2021, it is projected to reach US$ 6,042.05 Million by 2028.
As per our report Asia Pacific Nitinol Medical Devices Market, the market size is valued at US$ 3,581.36 Million in 2021, projecting it to reach US$ 6,042.05 Million by 2028. This translates to a CAGR of approximately 7.8% during the forecast period.
The Asia Pacific Nitinol Medical Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Nitinol Medical Devices Market report:
The Asia Pacific Nitinol Medical Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Nitinol Medical Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Nitinol Medical Devices Market value chain can benefit from the information contained in a comprehensive market report.